A solid-phase competitive radioimmunoassay for the insulin receptor.

Area of Science:

• Biochemistry
• Immunology
• Endocrinology

Background:

• The insulin receptor plays a crucial role in glucose metabolism and cellular signaling.
• Accurate quantification and characterization of insulin receptors are essential for understanding metabolic diseases.

Purpose of the Study:

• To develop a reproducible radioimmunoassay for quantifying insulin receptors.
• To enable the examination of different receptor regions and phosphorylation status.
• To monitor changes in insulin receptor levels under physiological conditions.

Main Methods:

• Development of a radioimmunoassay using monoclonal anti-receptor antibodies.
• Immobilization of antibodies on microtiter wells for competitive binding assays.
• Utilizing antibodies specific to different receptor domains (cytoplasmic, autophosphorylation site).

Main Results:

• The assay demonstrated high reproducibility and sensitivity, detecting as little as 7 ng of insulin receptor.
• The assay successfully quantified insulin receptors from different species and tissues.
• The method could assess receptor phosphorylation status and monitor receptor downregulation in insulin-treated lymphocytes.

Conclusions:

• A novel radioimmunoassay provides a sensitive and specific method for insulin receptor quantification.
• This assay allows for the assessment of receptor status, including phosphorylation.
• The developed radioimmunoassay is valuable for studying insulin receptor dynamics in various physiological and pathological states.